Eli Lilly and Company
ANTI-CD137 ANTIBODIES
Last updated:
Abstract:
The present invention relates to antibodies that bind to human CD137 and display agonist activity, and may be useful for treating solid and hematological tumors alone and in combination with chemotherapy and ionizing radiation.
Status:
Application
Type:
Utility
Filling date:
23 Jan 2020
Issue date:
21 May 2020